Silence Therapeutics | SLN - Revenu Net

Prix De L'Action
7.59
Variation Quotidienne
-0.01 -0.13%
Mensuellement
9.84%
Annuel
141.72%
Q2 Prévisions
5.62




Revenu Net Changement Date
AstraZeneca USD 2.33B 207M 2025-12
Autolus Therapeutics Ltd USD -90.33M 11.21M 2025-12
Hikma Pharmaceutical USD 164M 45M 2025-12
Novartis USD 2.41B 1.52B 2025-12
Roche Holding CHF 5.47B 1.76B 2025-12
Silence Therapeutics USD -11.77M 9.19M 2025-12